Industry
Biotechnology
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Loading...
Open
2.31
Mkt cap
162M
Volume
15K
High
2.32
P/E Ratio
-5.40
52-wk high
3.40
Low
2.30
Div yield
N/A
52-wk low
1.75
Portfolio Pulse from Benzinga Newsdesk
May 22, 2024 | 11:59 am
Portfolio Pulse from Benzinga Newsdesk
May 20, 2024 | 8:04 pm
Portfolio Pulse from Benzinga Newsdesk
May 16, 2024 | 5:38 pm
Portfolio Pulse from Benzinga Newsdesk
March 12, 2024 | 4:19 pm
Portfolio Pulse from Benzinga Newsdesk
March 08, 2024 | 2:51 pm
Portfolio Pulse from Benzinga Insights
January 10, 2024 | 9:31 pm
Portfolio Pulse from Benzinga Insights
December 15, 2023 | 3:01 pm
Portfolio Pulse from Benzinga Newsdesk
December 15, 2023 | 2:43 pm
Portfolio Pulse from Benzinga Newsdesk
November 20, 2023 | 1:31 pm
Portfolio Pulse from Benzinga Newsdesk
November 20, 2023 | 11:13 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.